Bernstein initiated coverage of Jazz Pharmaceuticals (JAZZ) with a Market Perform rating and $229 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals Rides Record Q1 and Oncology Gains
- Midday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV
- StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
- Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS
- Jazz Pharmaceuticals price target raised to $245 from $226 at Morgan Stanley